Journal rankings · indicator year 2025
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2025
Genetics journal rankings 2025
125 ranked journals · Subfield in Biochemistry, Genetics and Molecular Biology
Genetics has 125 ranked journals in 2025. The median journal has an OJR of 0.69, below the world average of 1.00, down 0.01 on 2024; Q1 starts at OJR 1.02. The two highest-scoring journals with stable ranks are Nature Ecology & Evolution and Genome Medicine: each is likely ranked within the top 3.
Ranks and citation indicators: 2025. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2022–2024, the window the 2025 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Biochemistry, Genetics and Molecular Biology (14)
125 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. The small range under it is the likely rank range: in 95% of 1,000 resamples of the journal’s papers, it ranked inside that range. Journals whose ranges overlap are not clearly different. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2024. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2022–2024, the window the 2025 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2022–2024 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2016 to 2025. A label compares the 2022→2025 change with the median change of the journal’s field or domain. Rising needs a relative change of +10% or more that is at least 2 standard errors above zero; Falling needs -9.1% or less (rounded), at least 2 standard errors below zero. Sorting uses that relative change. | Compare |
|---|---|---|---|---|---|---|---|
Rank 1; likely between #1 and #2 of 125Nature Ecology & EvolutionNature Portfolio · United Kingdom | 4.08Q1 | 10.83 1.36 up from 2024 | 883 | 44% | $12,690 | ||
Rank 2; likely between #1 and #2 of 125Genome MedicineOABioMed Central · United Kingdom | 3.68Q1 | 11.45 0.63 down from 2024 | 404 | 100% | $5,290 | ||
Rank 3; likely between #3 and #4 of 125The American Journal of Human GeneticsElsevier BV · United States | 2.49Q1 | 7.08 0.95 down from 2024 | 570 | 100% | $5,150 | ||
Rank 4; likely between #3 and #6 of 125Journal of Crohn s and ColitisOxford University Press · United Kingdom | 2.26Q1 | 7.51 0.97 up from 2024 | 582 | 50% | $4,790 | Rising vs field, 2022–25 | |
Rank 5; likely between #4 and #10 of 125Genetics in MedicineElsevier BV · United States | 1.89Q1 | 5.48 0.59 down from 2024 | 561 | 83% | $5,110 | ||
Rank 6; likely between #4 and #12 of 125npj Genomic MedicineOANature Portfolio · United Kingdom | 1.83Q1 | 5.81 0.55 up from 2024 | 179 | 100% | $4,190 | ||
Rank 7; likely between #4 and #15 of 125Animal FrontiersOAOxford University Press · United States | 1.80Q1 | 5.83 2.40 up from 2024 | 202 | 100% | $3,500 | ||
Rank 8; likely between #5 and #15 of 125United European Gastroenterology JournalWiley · United Kingdom | 1.69Q1 | 4.27 0.24 down from 2024 | 481 | 95% | $2,930 | Rising vs field, 2022–25 | |
Rank 9; likely between #5 and #17 of 125Evolution LettersOAWiley · United Kingdom | 1.67Q1 | 4.35 0.49 up from 2024 | 185 | 100% | $2,678 | Falling vs field, 2022–25 | |
Rank 10; likely between #6 and #18 of 125Molecular Therapy — OncolyticsOAElsevier BV · United States | 1.61Q1 | 4.89 0.40 down from 2024 | 221 | — | $3,900 | ||
Rank 11; likely between #8 and #19 of 125Genetics Selection EvolutionOABioMed Central · United Kingdom | 1.53Q1 | 4.49 1.20 up from 2024 | 250 | 100% | $2,390 | Falling vs field, 2022–25 | |
Rank 12; likely between #5 and #30 of 125Evolutionary Journal of the Linnean SocietyOAOxford University Press | 1.53Q1 | 3.40 2.60 up from 2024 | 48 | 100% | $2,326 | ||
Rank 13; likely between #9 and #18 of 125Inflammatory Bowel DiseasesOxford University Press · United States | 1.50Q1 | 4.71 0.66 up from 2024 | 873 | 47% | $3,862 | Rising vs field, 2022–25 | |
Rank 14; likely between #8 and #22 of 125Journal of Neurodevelopmental DisordersOABioMed Central · United Kingdom | 1.49Q1 | 3.98 0.90 down from 2024 | 168 | 100% | $2,990 | ||
Rank 15; likely between #3 and #62 of 125Genetic EpidemiologyWiley · United States | 1.45Q1 | 3.36 0.56 down from 2024 | 114 | 58% | $4,150 | Rising vs field, 2022–25 | |
Rank 16; likely between #5 and #32 of 125HereditySpringer Nature · United Kingdom | 1.45Q1 | 2.73 1.41 down from 2024 | 235 | 95% | $2,690 | ||
Rank 17; likely between #13 and #22 of 125Molecular EcologyWiley · United Kingdom | 1.37Q1 | 3.75 0.26 down from 2024 | 1,212 | 76% | $5,150 | Falling vs field, 2022–25 | |
Rank 18; likely between #14 and #24 of 125Evolutionary ApplicationsOAWiley · United Kingdom | 1.34Q1 | 3.30 0.23 down from 2024 | 432 | 100% | $4,320 | ||
Rank 19; likely between #9 and #34 of 125Cambridge Prisms Precision MedicineCambridge University Press | 1.33Q1 | 4.06 1.03 up from 2024 | 40 | 100% | $3,893 | ||
Rank 20; likely between #13 and #28 of 125Therapeutic Advances in GastroenterologyOASAGE Publishing · United Kingdom | 1.31Q1 | 4.17 0.04 down from 2024 | 404 | 100% | $2,700 | ||
Rank 21; likely between #10 and #37 of 125Toxicon XOAElsevier BV · United Kingdom | 1.29Q1 | 2.98 0.81 down from 2024 | 74 | 100% | $2,740 | ||
Rank 22; likely between #15 and #27 of 125Molecular Therapy — Methods & Clinical DevelopmentOACell Press · United States | 1.29Q1 | 4.42 0.08 down from 2024 | 564 | 100% | $3,900 | ||
Rank 23; likely between #16 and #30 of 125European Journal of Human GeneticsSpringer Nature · United Kingdom | 1.24Q1 | 3.81 0.19 down from 2024 | 685 | 96% | $2,790 | ||
Rank 24; likely between #19 and #28 of 125Orphanet Journal of Rare DiseasesOABioMed Central · United Kingdom | 1.22Q1 | 3.89 0.29 down from 2024 | 1,303 | 100% | $2,990 | ||
Rank 25; likely between #20 and #35 of 125Human GeneticsSpringer Science+Business Media · Germany | 1.14Q1 | 3.48 0.46 down from 2024 | 299 | 60% | $3,690 | Falling vs field, 2022–25 | |
Rank 26; likely between #21 and #35 of 125Journal of Medical GeneticsBMJ · United Kingdom | 1.13Q1 | 3.29 0.79 down from 2024 | 373 | 51% | — | ||
Rank 27; likely between #21 and #35 of 125BMC Ecology and EvolutionOABioMed Central · United Kingdom | 1.13Q1 | 2.76 0.04 down from 2024 | 359 | 100% | $2,890 | ||
Rank 28; likely between #20 and #39 of 125Human MutationWiley · United States | 1.10Q1 | 1.86 2.24 down from 2024 | 224 | 99% | $2,740 | ||
Rank 29; likely between #20 and #39 of 125AnthrozoösTaylor & Francis · United States | 1.10Q1 | 2.36 0.15 down from 2024 | 168 | 33% | — | ||
Rank 30; likely between #20 and #45 of 125Intestinal ResearchOAKorean Association for the Study of Intestinal Diseases · South Korea | 1.05Q1 | 3.58 0.23 up from 2024 | 154 | 100% | — | ||
Rank 31; likely between #20 and #48 of 125Journal of the Canadian Association of GastroenterologyOAOxford University Press · United Kingdom | 1.05Q1 | 3.08 0.31 up from 2024 | 133 | 100% | $2,198 | Rising vs field, 2022–25 | |
Rank 32; likely between #24 and #44 of 125Crohn s & Colitis 360OAOxford University Press · United States | 1.02Q1 | 2.57 0.02 down from 2024 | 215 | 100% | $3,378 | Rising vs field, 2022–25 | |
Rank 33; likely between #19 and #53 of 125Evolution Medicine and Public HealthOAUniversity of Oxford · United Kingdom | 1.01Q2 | 2.09 0.11 down from 2024 | 119 | 100% | $3,629 | ||
Rank 34; likely between #21 and #54 of 125American Journal of Medical Genetics Part C Seminars in Medical GeneticsWiley · United States | 0.98Q2 | 2.00 2.30 down from 2024 | 141 | 70% | $3,460 | ||
Rank 35; likely between #8 and #85 of 125Bulletin of the Society of Systematic BiologistsOAOhio State University Libraries · United States | 0.98Q2 | 1.94 1.54 down from 2024 | 42 | 100% | — | ||
Rank 36; likely between #30 and #43 of 125Digestive and Liver DiseaseOAElsevier BV · Italy | 0.97Q2 | 3.15 0.34 up from 2024 | 901 | 14% | $3,300 | Rising vs field, 2022–25 | |
Rank 37; likely between #24 and #51 of 125Genes Brain & BehaviorWiley · United Kingdom | 0.97Q2 | 2.63 0.06 up from 2024 | 116 | 87% | $3,540 | ||
Rank 38; likely between #31 and #44 of 125Forensic Science InternationalElsevier BV · Netherlands | 0.95Q2 | 2.83 0.21 up from 2024 | 809 | 47% | $4,580 | Falling vs field, 2022–25 | |
Rank 39; likely between #15 and #74 of 125The Application of Clinical GeneticsOADove Medical Press · New Zealand | 0.94Q2 | 2.98 0.28 down from 2024 | 57 | 100% | $2,320 | ||
Rank 40; likely between #30 and #47 of 125Human Genetics and Genomics AdvancesOAElsevier BV · United States | 0.93Q2 | 2.47 0.99 down from 2024 | 242 | 100% | $3,300 | ||
Rank 41; likely between #26 and #68 of 125Behavior GeneticsSpringer Science+Business Media · Netherlands | 0.87Q2 | 1.89 0.35 down from 2024 | 107 | 83% | $3,390 | ||
Rank 42; likely between #29 and #67 of 125Journal of Human GeneticsSpringer Nature · Japan | 0.86Q2 | 2.44 0.23 down from 2024 | 294 | 37% | $5,490 | ||
Rank 43; likely between #16 and #85 of 125New Genetics and SocietyOATaylor & Francis · United Kingdom | 0.85Q2 | 2.32 0.54 up from 2024 | 37 | 100% | $1,590 | ||
Rank 44; likely between #31 and #66 of 125Conservation GeneticsSpringer Science+Business Media · Netherlands | 0.84Q2 | 2.45 0.81 up from 2024 | 234 | 72% | $3,790 | ||
Rank 45; likely between #38 and #56 of 125Forensic Science International GeneticsElsevier BV · Netherlands | 0.83Q2 | 3.56 0.10 up from 2024 | 357 | 52% | $5,020 | ||
Rank 46; likely between #18 and #89 of 125Advances in Small Animal CareElsevier BV · Netherlands | 0.82Q2 | 2.61 1.58 up from 2024 | 48 | 18% | $3,000 | ||
Rank 47; likely between #41 and #58 of 125ToxiconElsevier BV · United Kingdom | 0.80Q2 | 2.45 0.24 down from 2024 | 921 | 23% | $3,340 | Rising vs field, 2022–25 | |
Rank 48; likely between #40 and #61 of 125Journal of Animal Breeding and GeneticsWiley · Germany | 0.79Q2 | 2.00 0.04 down from 2024 | 181 | 75% | $4,750 | Falling vs field, 2022–25 | |
Rank 49; likely between #35 and #70 of 125Frontline GastroenterologyBMJ · United Kingdom | 0.79Q2 | 2.06 0.03 down from 2024 | 286 | 33% | — | ||
Rank 50; likely between #30 and #83 of 125Molecular CytogeneticsOABioMed Central · United Kingdom | 0.75Q2 | 1.60 0.30 down from 2024 | 120 | 100% | $3,290 |
9 Genetics journals are labelled rising: their OJR moved up between 2022 and 2025 clearly faster than the median journal of their field or domain.
A journal is rising when its OJR grew from 2022 to 2025 faster than the median journal of its field (or domain, when the field is small), by two tests: the relative change is +10% or more, and it is at least 2 standard errors above zero. So the range of the change at 2 standard errors stays above zero, though not necessarily above +10%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the low end of the range, so the surest rises come first.
- 1Crohn s & Colitis 360OAOxford University Press · United States+171% vs groupOJR 0.41 → 1.02range +109% to +252%
- 2Medizinische GenetikSpringer Nature · Germany+168% vs groupOJR 0.15 → 0.36range +48% to +387%
- 3Journal of the Canadian Association of GastroenterologyOAOxford University Press · United Kingdom+107% vs groupOJR 0.55 → 1.05range +33% to +223%
- 4ToxiconElsevier BV · United Kingdom+54% vs groupOJR 0.57 → 0.80range +32% to +80%
- 5Inflammatory Bowel DiseasesOxford University Press · United States+43% vs groupOJR 1.14 → 1.50range +26% to +64%
- 6Digestive and Liver DiseaseOAElsevier BV · Italy+31% vs groupOJR 0.81 → 0.97range +14% to +51%
- 7United European Gastroenterology JournalWiley · United Kingdom+38% vs groupOJR 1.33 → 1.69range +12% to +70%
- 8Journal of Crohn s and ColitisOxford University Press · United Kingdom+38% vs groupOJR 1.78 → 2.26range +11% to +71%
- 9Genetic EpidemiologyWiley · United States+138% vs groupOJR 0.66 → 1.45range +9.6% to +416%
No-label zone, -9.1% to +10%Group median changeBar scale -82% to +460% (ratio scale)
10 Genetics journals are labelled falling: their OJR moved between 2022 and 2025 clearly behind the median journal of their field or domain.
A journal is falling when its OJR changed from 2022 to 2025 by less than the median journal of its field (or domain, when the field is small), by two tests: the relative change is -9.1% or less (rounded), and it is at least 2 standard errors below zero. So the range of the change at 2 standard errors stays below zero, though not necessarily below -9.1%.
The bar is that range on a ratio scale; the shaded band, -9.1% to +10%, holds changes too small for a label. The list is ordered by the high end of the range, so the surest falls come first.
- 1Molecular EcologyWiley · United Kingdom-22% vs groupOJR 1.91 → 1.37range -30% to -13%
- 2Human GeneticsSpringer Science+Business Media · Germany-26% vs groupOJR 1.68 → 1.14range -39% to -9.7%
- 3Genetics Selection EvolutionOABioMed Central · United Kingdom-25% vs groupOJR 2.22 → 1.53range -38% to -9.7%
- 4SociobiologyOAState University of Feira de Santana · Brazil-33% vs groupOJR 0.53 → 0.33range -51% to -7.7%
- 5Molecular Genetics & Genomic MedicineOAWiley · United States-16% vs groupOJR 0.68 → 0.53range -25% to -5.4%
- 6Journal of Animal Breeding and GeneticsWiley · Germany-23% vs groupOJR 1.13 → 0.79range -38% to -5.1%
- 7Animal GeneticsWiley · United Kingdom-21% vs groupOJR 0.90 → 0.65range -35% to -3.5%
- 8Forensic Science InternationalElsevier BV · Netherlands-12% vs groupOJR 1.17 → 0.95range -22% to -1.3%
- 9Evolution LettersOAWiley · United Kingdom-24% vs groupOJR 2.37 → 1.67range -41% to -0.6%
- 10Journal of HeredityOxford University Press · United States-27% vs groupOJR 1.12 → 0.75range -47% to -0.3%
No-label zone, -9.1% to +10%Group median changeBar scale -53% to +111% (ratio scale)
Subfields of Biochemistry, Genetics and Molecular Biology, with Genetics highlighted.
- Molecular Biology1,152
- Genetics125
- Cancer Research29
- Cell Biology28
- Molecular Medicine12
- Biophysics10
- Clinical Biochemistry4
- Biochemistry3
- Structural Biology2
- Developmental Biology1
- Physiology1
- Aging0
- Biotechnology0
- Endocrinology0
Journals
The endpoints below each rank show its likely range. How rank ranges are calculated
Citations made in 2025. Corpus-wide, 84.3% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
36 additional Genetics journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2022–2024, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2025. Publication window: 2022–2024. How these summaries are calculated
- Ranked journals
- 125
- Window papers (baseline)
- 122,023 +2.8% from indicator year 2022
- Median OJR
- 0.690 +1.1% from indicator year 2022
- Rising journals (2025)
- 9
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2022–2024 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 53 | 60 | 64 | 68 | 67 | 66 | 69 | 72 | 77 | 85 | 95 | 99 | 102 | 106 | 108 | 116 | 121 | 123 | 125 | 127 | 121 | 120 | 120 | 120 | 122 | 125 | |
| Window papers (baseline) | 49,162 | 54,673 | 58,350 | 62,005 | 62,764 | 66,635 | 71,118 | 76,704 | 81,233 | 88,092 | 94,309 | 99,614 | 100,646 | 100,795 | 102,423 | 105,797 | 108,204 | 109,120 | 108,752 | 109,623 | 111,294 | 114,679 | 118,670 | 119,863 | 119,840 | 122,023 | |
| Median OJR | 0.48 | 0.42992 | 0.42987 | 0.57 | 0.693 | 0.665 | 0.656 | 0.733 | 0.71 | 0.771 | 0.792 | 0.785 | 0.729 | 0.83 | 0.90 | 0.91 | 0.8550 | 0.8040 | 0.8551 | 0.8041 | 0.75 | 0.766 | 0.68 | 0.67 | 0.70 | 0.690 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.